Stock listing

Precigen, Inc.

Selected listing: A2PZG1 · LS · EUR · DE

Precigen, Inc. (Lang & Schwarz: A2PZG1), Health Technology. Latest release Sep 21, 2026: Precigen Receives FDA Platform Technology Designation for AdenoVerse…

A2PZG1:LSEURDEUpdated September 25, 2026

Ticker: Lang & Schwarz: A2PZG1
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: Lang & Schwarz
Currency: EUR

Latest news from Precigen, Inc.

Precigen Receives FDA Platform Technology Designation for AdenoVerse Platform

September 21, 2026

Precigen Reports Second Quarter 2026 Financial Results Highlighted by Accelerating PAPZIMEOS Revenue Growth

August 4, 2026

Precigen to Announce Second Quarter 2026 Financial Results and Provide Business Updates on August 4

July 21, 2026

Precigen Gains Advantage as PAPZIMEOS Granted Orphan Drug Exclusivity by FDA; Long-Term Data From Clinical Study Encouraging

June 14, 2026

Precigen and the Recurrent Respiratory Papillomatosis Foundation Recognize International RRP Awareness Day by Elevating Patient and Community Voices

June 11, 2026

All Precigen, Inc. news →

Events

Replays

Precigen, Inc. (PGEN) Q2 2026 Earnings Call
Tue, Aug 04, 2026 · 04:30 PM ET
Watch
Precigen, Inc. (PGEN) Q1 2026 Earnings Call
Wed, May 13, 2026 · 04:30 PM ET
Watch
Precigen, Inc. (PGEN) Q4 2025 Earnings Call
Wed, Mar 25, 2026 · 04:30 PM ET
Watch

Research Precigen, Inc.

Precigen, Inc. company profile

View the public company page for Precigen, Inc. on 6ix.

Precigen, Inc. news

Read company news and market updates connected to Precigen, Inc..

Precigen, Inc. investor events

Find investor webinars, events, and replay context for Precigen, Inc..